Synthorx, Inc. THOR
We take great care to ensure that the data presented and summarized in this overview for Synthorx, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in THOR
Top Purchases
Top Sells
About THOR
Insider Transactions at THOR
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 23
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
9,724,598
-100.0%
|
$661,272,664
$68.0 P/Share
|
|
Dec 11
2018
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,545,455
+31.85%
|
$50,000,005
$11.0 P/Share
|
|
Dec 11
2018
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
5,179,143
+45.68%
|
-
|
|
Dec 11
2018
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
3,952,719
+42.64%
|
-
|
|
Dec 11
2018
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,363,636
+50.0%
|
$14,999,996
$11.0 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders